Lacrimal gland carcinoma ex pleomorphic adenoma

Summary

Lacrimal gland carcinoma ex pleomorphic adenoma (MONDO:0002469) is a cancer. A subtype of lacrimal gland carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lacrimal gland carcinoma ex pleomorphic adenoma
Mondo ID	MONDO:0002469
DOID	DOID:296
NCIT	C6804
SNOMED CT	254989000
UMLS	C0346342
MedGen	138058
Anatomy (UBERON)	UBERON:0001817
Is cancer (heuristic)	yes

Also known as: carcinoma ex pleomorphic adenoma of lacrimal gland · carcinoma Ex pleomorphic adenoma of the lacrimal gland · carcinoma ex pleomorphic adenoma of the lacrimal gland · lacrimal gland carcinoma ex pleomorphic adenoma · lacrimal gland malignant mixed neoplasm · lacrimal gland malignant mixed tumor · lacrimal gland malignant mixed tumour · malignant mixed neoplasm of lacrimal gland · malignant mixed neoplasm of the lacrimal gland · malignant mixed tumor of lacrimal gland · malignant mixed tumor of the lacrimal gland · malignant mixed tumour of lacrimal gland · malignant mixed tumour of the lacrimal gland

Disease family

Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › lacrimal apparatus disorder › lacrimal system cancer › lacrimal gland cancer › lacrimal gland carcinoma › lacrimal gland carcinoma ex pleomorphic adenoma

Related subtypes (2): lacrimal gland adenocarcinoma, lacrimal gland squamous cell carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.